5% Amino acids, carbohydrates, electrolytes and vitamines
Composition
| 1000 ml infusion solution contains: | |||
|---|---|---|---|
| Amino acids : | |||
| L-Isoleucine | 1.55 g | ||
| L-Leucine | 2.20 g | ||
| L-Lysine monohydrochloride | 2.50 g | ||
| L-Methionine | 2.10 g | ||
| L-Phenylalanine | 2.20 g | ||
| L-Threonine | 1.00 g | ||
| L -Tryptophan | 0.45 g | ||
| L-Valine | 1.50 g | ||
| L-Alanine | 6.00 g | ||
| L-Arginine | 4.00 g | ||
| L-Glutamic acid | 9.00 g | ||
| Glycine | 10.00 g | ||
| L-Histidine | 1.00 g | ||
| L-Proline | 7.00 g | ||
Calorie sources: | |||
| Sorbitol | 50.00 g | ||
| Xylitol | 50.00 g | ||
Vitamins: | |||
| Ascorbic acid | 0.40 g | ||
| Inositol | 0.50 g | ||
| Nicotinamide | 0.06 g | ||
| Pyridoxine hydrochloride (B6) | 0.04 g | ||
| Riboflavin-5'-phosphate sodium salt (B2) | 0.0025 g | ||
Electrolytes : | |||
| Potassium hydroxide | 1.68 g | ||
| Magnesium acetate | 1.07 g | ||
| Sodium hydroxide | 1.60 g | ||
| L-Malic acid | 2.01 g | ||
In water for injection | |||
| Yielding: | mEq/l | mmol/l | mg/l |
|---|---|---|---|
| Na + | 40 | 40 | 920 |
| K + | 30 | 30 | 1173 |
| Mg ++ | 10 | 5 | 121 |
| Acetate - | 10 | 10 | 589 |
| Malate - | 15 | 15 | 1995 |
| Cl - | 14 | 14 | 492 |
Description
Requirement-adapted fully-balanced L-amino acid solution with carbohydrates, vitamins and electrolytes. The figure incorporated in the product name designates the approximate calorie content per litre.
Total nitrogen content: 7.6 g/l
True Osmolarity: approx. 1100 mOsm/l
Indications
Solution for total parenteral nutrition supplying protein building blocks, electrolytes, energy, vitamins and water.
Dosage Instructions
For intravenous infusion.
Dosage according to amino acid requirements, unless otherwise prescribed:
Dosage
ml/kg/BW/day*)
|
Average
ml/kg BW/h
|
Infusion rate
Drops/ min***)
| |
15 to 60
|
3
|
70
| |
| *) | equivalent to 3 g sorbitol or xylitol/kg BW/day or 0.75 - 3.0 g amino acids/kg BW/day | ||
| ***) | For average adult weighing 70 kg | ||
Side Effects and Adverse Reactions
If amino acid solutions are infused too rapidly renal losses will occur and, in susceptible patients, nausea, flushing etc.
Reactions which may occur because of the solution or the technique of administration include fibrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extra vasation and hyper volemia.
If an adverse reaction occurs, discontinue infusion. Initiate appropriate treatment and retain the remainder of the fluid for examination if deemed necessary.
Contraindications
The solution should not be used in patients with: shock, severe acute renal disease, unknown renal function, hyperkalaemia, fructose-sorbitol intolerance, fructose 1-6 diphosphate deficiency, methyl alcohol poisoning, disturbances of amino acid metabolism.
Presentation and Pack Sizes
Infusion solution in bottles containing 500 ml.
Clinic pack available with 10 bottles.
Special Notes
Use with care in cases of decompensated cardiac insufficiency. Ensure adequate renal function. Use only clear solution in condition of intact container.
Store below 25°C. Protect from light.
Reg. No. DKL0411637149A1
HARUS DENGAN RESEP DOKTER.
Manufactured by:
PT Finusolprima Farma Internasional, Bekasi - Indonesia
For:
PT KALBE FARMA Tbk., Bekasi - Indonesia
Under license from:
Baxter Deutschland GMBH, Germany
0 Komentar
Penulisan markup di komentar